Loading…

Solventum announced a definitive agreement to acquire Acera Surgical for $725 million in cash plus up to $125 million in contingent payments, expanding into synthetic tissue matrices.
“Expanding our advanced wound care portfolio into the high-growth synthetic tissue matrices category complements solutions within our existing portfolio.”news.solventum.com
Summarized from public sources; check the original articles before acting on it.